Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Current Deferred Revenue (2018 - 2025)

INVO Fertility has reported Current Deferred Revenue over the past 8 years, most recently at $720407.0 for Q3 2025.

  • Quarterly Current Deferred Revenue rose 28.09% to $720407.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $720407.0 through Sep 2025, up 28.09% year-over-year, with the annual reading at $602359.0 for FY2024, 47.36% up from the prior year.
  • Current Deferred Revenue was $720407.0 for Q3 2025 at INVO Fertility, down from $834850.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $3.4 million in Q1 2021 and troughed at $5793.0 in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $416745.0 (2024), against an average of $544797.6.
  • The largest YoY upside for Current Deferred Revenue was 1931.8% in 2022 against a maximum downside of 99.83% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $5900.0 in 2021, then skyrocketed by 1931.8% to $119876.0 in 2022, then surged by 240.99% to $408769.0 in 2023, then surged by 47.36% to $602359.0 in 2024, then grew by 19.6% to $720407.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Current Deferred Revenue are $720407.0 (Q3 2025), $834850.0 (Q2 2025), and $725330.0 (Q1 2025).